This message is to serve as an announcement to the biological industry
that a Parkinson's treament (approved for clinical trials) is
available for license. This product offers a similar modality to that
of foetal implants without ethical conflicts, possible
biocontamination, and product variance. More information will be given
to interested parties upon request.
Address inquires to:
amanda.mcrae at anatcell.gu.se
Or fax Amanda McRae at: +46-31-829690
